蘋果和 Masimo 的法律糾紛現已向前邁出了一小步

特拉華州陪審團裁定智慧手錶製造商 Masimo 侵犯了蘋果 Apple Watch 的健康技術專利，但僅限於不再銷售的舊款智慧手錶，並在合法範圍內判給該公司最小的損害賠償。

A Delaware jury has found smartwatch maker Masimo guilty of infringing two of Apple's Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and awarded the firm the least damages it legally could.

特拉華州陪審團裁定智慧手錶製造商 Masimo 侵犯了蘋果 Apple Watch 的兩項健康技術專利，但僅限於不再銷售的舊款智慧手錶，並在合法範圍內判給該公司最小的損害賠償。

In the suit just decided, Apple accused Masimo in 2022 of infringing two of its own design patents to "make way for its own watch." The jury has now found Masimo guilty of the charge for Masimo's former Freedom and W1 smartwatches, but said the company was not guilty of infringement on any current products.

在剛剛判決的訴訟中，蘋果指控Masimo在2022年侵犯了自己的兩項設計專利，以「為自己的手錶讓路」。陪審團現在裁定 Masimo 對 Masimo 之前的 Freedom 和 W1 智慧手錶的指控有罪，但表示該公司對任何當前產品均不存在侵權行為。

It awarded Apple a token $250 in damages, the legal minimum for infringement. Apple's attorneys had sought a sales injunction against current Masimo products it said were infringing Apple's patents, but that charge was denied by the jury, Reuters has reported.

它判蘋果象徵性地賠償 250 美元，這是侵權的法定最低賠償額。根據路透社報道，蘋果公司的律師曾尋求針對目前 Masimo 產品的銷售禁令，稱其侵犯了蘋果的專利，但陪審團否認了這項指控。

Apple said in a statement that it was pleased that the ruling "will protect the innovations we advance on behalf of our customers." Masimo said that "Apple primarily sought an injunction against Masimo's current products, and the jury's verdict is a victory for Masimo on that issue."

蘋果在一份聲明中表示，很高興該裁決「將保護我們代表客戶推進的創新」。馬西莫表示，“蘋果主要尋求針對馬西莫當前產品的禁令，陪審團的裁決是馬西莫在這個問題上的勝利。”

Calling Apple's suit retaliatory, Masimo noted that the jury ruled on its behalf on "nearly" all the disputed issues, and that the patent infringement decision applied only "a discontinued module and charger."

馬西莫稱蘋果公司的訴訟是報復性的，並指出陪審團代表其對「幾乎」所有有爭議的問題做出了裁決，專利侵權裁決僅適用於「已停產的模組和充電器」。

The two companies have been embroiled in a fight over smartwatch health technology. Masimo has previously accused Apple of hiring away its employees and copying aspects of its pulse oximetry technology following failed collaboration talks.

兩家公司捲入了智慧手錶健康技術之爭。馬西莫先前曾指責蘋果公司在合作談判失敗後挖走了員工並抄襲其脈搏血氧儀技術的某些方面。

Masimo scored a significant victory in its claims in 2023, when the US International Trade Commission temporarily blocked imports of Apple's Series 9 and Ultra 2 watches. Apple is appealing that verdict, but complied with the ITC ruling by disabling the feature.

Masimo 在 2023 年的索賠中取得了重大勝利，當時美國國際貿易委員會暫時阻止了蘋果 Series 9 和 Ultra 2 手錶的進口。蘋果公司正在對該判決提出上訴，但遵守了國際貿易委員會的裁決，禁用了該功能。

It was then was able to resume sales of the Apple Watch. Current models of the Apple Watch continue to include the blood oxygen sensing technology, but it remains disabled until the dispute is settled.

隨後蘋果手錶的銷售得以恢復。目前的 Apple Watch 型號繼續配備血氧感測技術，但在爭議解決之前該技術仍處於禁用狀態。

Users with older Apple Watch models, up to the Apple Watch Series 8, can still use the disputed blood oxygen measuring feature.

使用較舊 Apple Watch 型號（直至 Apple Watch Series 8）的用戶仍然可以使用有爭議的血氧測量功能。

Apple could appeal this most recent decision, forcing the dispute to take longer to resolve. Masimo has now won decisive victories against Apple with both the ITC and a juried trial, which may be enough to get Apple executives to rethink its current legal strategy.

蘋果可能會對最新的決定提出上訴，迫使爭議需要更長的時間才能解決。馬西莫現在在國際貿易委員會和陪審團審判中都贏得了對蘋果的決定性勝利，這可能足以讓蘋果高層重新考慮目前的法律策略。

Separately, Masimo's CEO stepped down from the role in September 2024. Joe Kiani's move was not, however, related to the Apple Watch dispute.

另外，Masimo 的執行長於 2024 年 9 月辭去了這項職務。